FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gabrielle Fisher

Research Profile

Disorders

Chemicals & Drugs

Prostate Specific Antigen

Anatomy

Concepts & Ideas

Procedures

Geographic Areas

Great Britain

Co-author Network

Publications

TOP 3
S S Jeetle; Henrik Møller; E Stankiewicz; Z H Yang; Daniel M Berney; C S Cooper; Jack Cuzick; Gabrielle Fisher
Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer.
Jack Cuzick; Gregory Swanson; Gabrielle Fisher; Arthur R Brothman; Daniel M Berney; Julia E Reid; David Mesher; V O Speights; Elzbieta Stankiewicz; Christopher S Foster; Henrik Møller; Peter Scardino; Jorja D Warren; Jimmy Park; Adib Younus; Darl D Flake; Susanne Wagner; Alexander Gutin; Jerry S Lanchbury; Steven Stone
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.
Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Henrik Møller; Tim Oliver; Victor Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gabrielle Fisher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: S S Jeetle; Henrik Møller; E Stankiewicz; Z H Yang; Daniel M Berney; C S Cooper; Jack Cuzick; Gabrielle Fisher
Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer.
Virchows Archiv : an international journal of pathology 2012;461(2):103-7.
2011: Jack Cuzick; Gregory Swanson; Gabrielle Fisher; Arthur R Brothman; Daniel M Berney; Julia E Reid; David Mesher; V O Speights; Elzbieta Stankiewicz; Christopher S Foster; Henrik Møller; Peter Scardino; Jorja D Warren; Jimmy Park; Adib Younus; Darl D Flake; Susanne Wagner; Alexander Gutin; Jerry S Lanchbury; Steven Stone
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.
The lancet oncology 2011;12(3):245-55.
2011: Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Henrik Møller; Tim Oliver; Victor Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(1):58-63.
2010: Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Tim Oliver; Henrik Møller; Victor E Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
Virchows Archiv : an international journal of pathology 2010;457(5):547-53.
2010: Martin K Thomsen; Laurence Ambroisine; Sarah Wynn; Kathryn S E Cheah; Christopher S Foster; Gabrielle Fisher; Daniel M Berney; Henrik Møller; Victor E Reuter; Peter T Scardino; Jack Cuzick; Narasimhan Ragavan; Paras B Singh; Francis L Martin; Christopher M Butler; Colin S Cooper; Amanda Swain
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.
Cancer research 2010;70(3):979-87.
2008: Michael W Kattan; Jack Cuzick; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.
Cancer 2008;112(1):69-74.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.
BJU international 2007;100(6):1240-4.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.
Histopathology 2007;51(4):452-7.
2006: Jack Cuzick; Gabrielle Fisher; Michael W Kattan; Daniel M Berney; T Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Long-term outcome among men with conservatively treated localised prostate cancer.
British journal of cancer 2006;95(9):1186-94.